Leaflet TETRACT-HIB lyophilisate and suspension for suspension for injection
Indicated for: active immunization
Route of administration: injectable
Substance: DTPW + HIB combination vaccine (vaccine)
ATC: J07AG52 (Antiinfectives for systemic use | Bacterial vaccines | Haemophilus influenzae B vaccines)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Store in the refrigerator as instructed in the leaflet.
Store protected from light.
The combined DTPw+Hib vaccine is used for active immunization against diphtheria, tetanus, pertussis (whooping cough), and infections caused by Haemophilus influenzae type B (Hib). This vaccine contains components of diphtheria and tetanus toxoids, inactivated whole cells of Bordetella pertussis, and the Hib capsular polysaccharide conjugated to a carrier protein.
The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants and young children. It is essential for preventing serious diseases such as meningitis, epiglottitis, and septicemia caused by Hib, as well as complications associated with diphtheria, tetanus, and whooping cough.
Common side effects include fever, irritability, drowsiness, and pain at the injection site. In rare cases, severe allergic reactions may occur.
The combined DTPw+Hib vaccine is a crucial measure for protecting public health, helping to reduce the incidence of these infectious diseases and prevent severe complications associated with them.
General data about TETRACT-HIB
- Substance: DTPW + HIB combination vaccine
- Date of latest medicines list: 01-07-2013
- Product code: W42456001
- Pharmaceutical form: lyophilisate and suspension for suspension for injection
- Quantity: 1
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.